blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2460832

EP2460832 - TWEAK binding antibodies [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  12.09.2014
Database last updated on 06.07.2024
Most recent event   Tooltip12.09.2014Application deemed to be withdrawnpublished on 15.10.2014  [2014/42]
Applicant(s)For all designated states
Biogen Idec MA Inc.
14 Cambridge Center
Cambridge, Massachusetts 02142 / US
[2012/23]
Inventor(s)01 / Burkly, Linda C.
34 Winthrop Street
West Newton, MA 02465 / US
02 / Garber, Ellen
14 Donnell Street
Cambridge, MA 02138 / US
03 / Lugovskoy, Alexey
24 Center Street
Woburn, MA 01801 / US
 [2012/23]
Representative(s)Miller, David James
Mathys & Squire The Shard
32 London Bridge Street
London SE1 9SG / GB
[N/P]
Former [2012/23]Miller, David James
Mathys & Squire LLP 120 Holborn
London EC1N 2SQ / GB
Application number, filing date11191813.225.05.2006
[2012/23]
Priority number, dateUS20050685149P27.05.2005         Original published format: US 685149 P
[2012/23]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP2460832
Date:06.06.2012
Language:EN
[2012/23]
Type: A3 Search report 
No.:EP2460832
Date:31.10.2012
Language:EN
[2012/44]
Search report(s)(Supplementary) European search report - dispatched on:EP01.10.2012
ClassificationIPC:C07K16/28, A61P35/00, A61K39/395
[2012/23]
CPC:
C07K16/2875 (EP,US); C07K16/00 (KR); A61P19/02 (EP);
A61P25/00 (EP); A61P25/28 (EP); A61P29/00 (EP);
A61P35/00 (EP); A61P37/00 (EP); A61P37/02 (EP);
A61P37/06 (EP); A61P43/00 (EP); A61P9/00 (EP);
A61P9/10 (EP); C12P21/00 (KR); A61K2039/505 (EP,US);
C07K2317/24 (EP,US); C07K2317/76 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2012/23]
TitleGerman:TWEAK-bindende Antikörper[2012/23]
English:TWEAK binding antibodies[2012/23]
French:Anticorps se liant à TWEAK[2012/23]
Examination procedure25.04.2013Examination requested  [2013/23]
13.08.2013Amendment by applicant (claims and/or description)
04.11.2013Despatch of a communication from the examining division (Time limit: M06)
15.05.2014Application deemed to be withdrawn, date of legal effect  [2014/42]
11.06.2014Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2014/42]
Parent application(s)   TooltipEP06760258.1  / EP1888113
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20060760258) is  08.12.2009
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report
13.08.2013Request for further processing filed
13.08.2013Full payment received (date of receipt of payment)
Request granted
23.08.2013Decision despatched
Fees paidRenewal fee
02.12.2011Renewal fee patent year 03
02.12.2011Renewal fee patent year 04
02.12.2011Renewal fee patent year 05
02.12.2011Renewal fee patent year 06
25.05.2012Renewal fee patent year 07
28.05.2013Renewal fee patent year 08
26.03.2014Renewal fee patent year 09
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]US2005008636  (RENNERT PAUL [US]) [X] 1-16* the whole document *;
 [I]  - POTROVITA I ET AL, "TUMOR NECROSIS FACTOR-LIKE WEAK INDUCER OF APOPTOSIS-INDUCED NEURODEGENERATION", JOURNAL OF NEUROSCIENCE, NEW YORK, NY, US, (20040922), vol. 24, no. 38, doi:10.1523/JNEUROSCI.1089-04.2004, ISSN 0270-6474, pages 8237 - 8244, XP009045900 [I] 1-16 * abstract * * page 8239, column l, paragraph 3 *

DOI:   http://dx.doi.org/10.1523/JNEUROSCI.1089-04.2004
 [I]  - POTROVITA I ET AL, "TWEAK - A REGULATOR OF NEURONAL CELL DEATH", NAUNYN-SCHMIEDEBERG'S ARCHIVES OF PHARMACOLOGY, SPRINGER, BERLIN, DE, (20040309), vol. 369, no. SUPPL. 01, ISSN 0028-1298, page R12, XP009045913 [I] 1-16 * the whole document *
 [I]  - CHICHEPORTICHE YVES ET AL, "Proinflammatory activity of TWEAK on human dermal fibroblasts and synoviocytes: blocking and enhancing effects of anti-TWEAK monoclonal antibodies", ARTHRITIS RESEARCH, CURRENT SCIENCE, LONDON, GB, (20011109), vol. 4, no. 2, doi:10.1186/ar388, ISSN 1465-9905, pages 126 - 133, XP021020655 [I] 1-16 * abstract * * page 126, column l, paragraph 1 - page 127, column l, paragraph 4 * * page 133, column l, paragraph l *

DOI:   http://dx.doi.org/10.1186/ar388
 [I]  - JAKUBOWSKI A ET AL, "Dual role for TWEAK in angiogenic regulation", JOURNAL OF CELL SCIENCE, CAMBRIDGE UNIVERSITY PRESS, LONDON, GB, (20020101), vol. 115, no. 2, ISSN 0021-9533, pages 267 - 274, XP002974742 [I] 1-16 * page 268, column l, paragraph l - column r, paragraph 1 *
 [I]  - NAKAYAMA M ET AL, "Characterization of murine TWEAK and its receptor (Fn14) by monoclonal antibodies", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS INC. ORLANDO, FL, US, (20030711), vol. 306, no. 4, doi:10.1016/s0006-291x(03)01051-9, ISSN 0006-291X, pages 819 - 825, XP004432093 [I] 1-16 * page 820, column r, paragraph 3 *

DOI:   http://dx.doi.org/10.1016/S0006-291X(03)01051-9
by applicantUS4399216
 DE3218121
 US4439196
 US4447233
 US4447224
 US4475196
 US4485045
 US4486194
 US4487603
 US4544545
 US4596556
 US4634665
 WO8705330
 US4790824
 WO9002809
 US4941880
 WO9007861
 US5064413
 WO9117271
 WO9201047
 WO9209690
 EP0502814
 WO9215679
 WO9218619
 WO9220791
 US5179017
 WO9301288
 US5223409
 US5225539
 US5312335
 US5383851
 US5399163
 US5530101
 WO9634096
 WO9633735
 US5585089
 US5624821
 US5641640
 US5648260
 US5658727
 US5667988
 US5693761
 US5693762
 WO9852976
 US5849992
 US5859205
 US5869046
 US5885793
 WO0034317
 US6300064
 US6407213
 US2003070185
 US2003211993
 US2005008625
 US2005037000
 US2005079574
    - SALEH ET AL., CANCER IMMUNOL. IMMUNOTHER., (1990), vol. 32, pages 180 - 190
    - LOBUGLIO ET AL., HYBRIDOMA, (1986), vol. 5, pages 5117 - 5123
    - CHOTHIA ET AL., J. MOL. BIOL., (1992), vol. 227, pages 799 - 817
    - TOMLINSON ET AL., J. MOL. BIOL., (1992), vol. 227, pages 776 - 798
    - TOMLINSON ET AL., EMBO J., (1995), vol. 14, page 4628
    - Current Protocols in Molecular Biology, JOHN WILEY & SONS, (1989), pages 6.3.1 - 6.3.6
    - SMITH, SCIENCE, (1985), vol. 228, pages 1315 - 1317
    - GREEN ET AL., NATURE GENETICS, (1994), vol. 7, pages 13 - 21
    - MORRISON, S. L., SCIENCE, (1985), vol. 229, pages 1202 - 1207
    - OI ET AL., BIOTECHNIQUES, (1986), vol. 4, page 214
    - TOMLINSON, I.A. ET AL., J. MOL. BIOL., (1992), vol. 227, pages 776 - 798
    - COOK, G. P. ET AL., IMMUNOL. TODAY, (1995), vol. 16, pages 237 - 242
    - CHOTHIA, D. ET AL., J. MOL. BIO., (1992), vol. 227, pages 799 - 817
    - TOMLINSON ET AL., EMBO J, (1995), vol. 14, pages 4628 - 4638
    - TOMLINSON, I.A. ET AL., MRC CENTRE FOR PROTEIN ENGINEERING
    - TEMPEST ET AL., BIOTECHNOLOGY, (1991), vol. 9, pages 266 - 271
    - ANGAL ET AL., MOL. IMMUNOL., (1993), vol. 30, pages 105 - 08
    - APLIN; WRISTON, CRC CRIT. REV. BIOCHEM., (1981), vol. 22, pages 259 - 306
    - HAKIMUDDIN ET AL., ARCH. BIOCHEM. BIOPHYS., (1987), vol. 259, page 52
    - EDGE ET AL., ANAL. BIOCHEM., (1981), vol. 118, page 131
    - THOTAKURA ET AL., METH. ENZYMOL., (1987), vol. 138, page 350
    - LUND ET AL., J. IMMUN., (1991), vol. 147, pages 2657 - 62
    - MORGAN ET AL., IMMUNOLOGY, (1995), vol. 86, pages 319 - 24
    - DAVIES ET AL., PROTEIN ENG., (1996), vol. 9, no. 6, pages 531 - 7
    - POWERS ET AL., JLMMUNOL METHODS., (2001), vol. 251, pages 123 - 35
    - URLAUB; CHASIN, PROC. NATL. ACAD. SCI. USA, (1980), vol. 77, pages 4216 - 4220
    - KAUFMAN; SHARP, MOL. BFOL., (1982), vol. 159, pages 601 - 621
    - BURTON; WOOF, ADV IMMUNOL., (1992), vol. 51, pages 1 - 84
    - JEFFERIS ET AL., IMMUNOL. REV., (1998), vol. 163, pages 59 - 76
    - CHICHEPORTICHE ET AL., ARTHRITIS RES., (2002), vol. 4, no. 2, pages 126 - 133
    - SJOLANDER; URBANICZKY, ANAL CHEM., (1991), vol. 63, pages 2338 - 2345
    - SZABO ET AL., CURR. OPIN. STRUCT. BIOI., (1995), vol. 5, pages 699 - 705
    - JOHNE ET AL., J. IMMUNOL. METHODS, (1993), vol. 160, pages 191 - 198
    - STUART ET AL., J. CLIN. INVEST., (1982), vol. 69, pages 673 - 683
    - POSER ET AL., ANN. NEUROL., (1983), vol. 13, page 227
    - KURTZKE, NEUROLOGY, (1983), vol. 33, page 1444
    - KURTZKE, ANN. NEUROL., (1994), vol. 36, pages 573 - 79
    - TUOHY ET AL., J. IMMULWL., (1988), vol. 141, pages 1126 - 1130
    - SOBEL ET AL., J. IMMUNOL., (1984), vol. 132, pages 2393 - 2401
    - TRAUGOTT, CELL IMMUNOL., (1989), vol. 119, pages 114 - 129
    - BERGE, S.M. ET AL., J. PHARNI. SCI., (1977), vol. 66, pages 1 - 19
    - ROUX ET AL., PROC NATL ACAD SCI USA, (1989), vol. 86, pages 9079 - 9083
    - CURR GENE THER., (2005), vol. 5, pages 63 - 70
    - HUM GENE THER., (2004), vol. 15, pages 1034 - 1044
    - DUZGUNES ET AL., J. CELL. BIOCHEM, (1992), vol. 16, page E 77
    - EPSTEIN ET AL., PROC. NATL. ACAD. SCI. USA, (1985), vol. 82, pages 3688 - 92
    - HWANG ET AL., PROC. NATL. ACAD. SCI. USA, (1980), vol. 77, pages 4030 - 34
    - COLCHER ET AL., METH. ENZYMOL., (1986), vol. 121, pages 802 - 816
    - "Developments in Antibody Imaging", A.R. BRADWELL ET AL., Monoclonal Antibodies for Cancer Detection and Therapy, ACADEMIC PRESS, (1985), pages 65 - 85
    - PYKETT, SCIENTIFIC AMERICAN, (1982), vol. 246, pages 78 - 88
 US20050653811
 US20050653813
 US20050679518
 US20050685465
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.